Instituto Grifols, S.A.

Form 483 issued June 25, 2019 · Parets Del Valles, Spain

Inspection
May 6 – Jun 25, 2019
Investigator
Gene Arey
Observations
2
Pages
2
FEI number
3002807257

In short: On June 25, 2019, FDA issued a Form 483 with 2 observations to Instituto Grifols, S.A. in Parets Del Valles, Spain (FEI 3002807257) after an inspection that ran May 6 – Jun 25, 2019. The investigator was Gene Arey. Most observations concern quality system and biologics CGMP; the most-cited regulation is 21 CFR 600.80 (postmarketing reporting of adverse experiences).

At a glance

Quality system and biologics cgmp account for 2 of 2 observations.

Quality system1
Biologics CGMP1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    The Quality Unit lacks authority to fully investigate…

  2. 02

    Regarding the follow-up of adverse experiences, investigations…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Instituto Grifols, S.A.?

FDA listed 2 observations on this Form 483, mostly about quality system and biologics CGMP. The most-cited regulation is 21 CFR 600.80 (postmarketing reporting of adverse experiences). The opening words of each observation are shown on this page.

Who inspected Instituto Grifols, S.A.?

Gene Arey is named on this Form 483, for the inspection of May 6 – Jun 25, 2019. Each investigator has a profile showing what they cite most.

When was Instituto Grifols, S.A. inspected by FDA?

The inspection ran May 6 – Jun 25, 2019, and the Form 483 is dated June 25, 2019.

How do I get the full Form 483 for Instituto Grifols, S.A.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free